Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS
· Delayed Price · Currency is USD
46.69
-5.18 (-9.99%)
At close: Jul 3, 2025
Chugai Pharmaceutical Cash Flow Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 410,150 | 387,317 | 325,472 | 374,429 | 302,995 | 214,733 | Upgrade
|
Depreciation & Amortization | 32,065 | 31,665 | 31,740 | 31,434 | 30,868 | 30,376 | Upgrade
|
Loss (Gain) From Sale of Assets | -1,421 | 4,377 | -21,881 | 641 | 6,342 | 953 | Upgrade
|
Asset Writedown & Restructuring Costs | 5,798 | - | - | - | - | - | Upgrade
|
Stock-Based Compensation | 383 | - | - | - | - | - | Upgrade
|
Other Operating Activities | -1,416 | -101,510 | -180,718 | -152,074 | -104,102 | -65,247 | Upgrade
|
Change in Other Net Operating Assets | -32,195 | 125,751 | 255,312 | -10,318 | 43,523 | 24,220 | Upgrade
|
Operating Cash Flow | 413,364 | 447,600 | 409,925 | 244,112 | 279,626 | 205,035 | Upgrade
|
Operating Cash Flow Growth | 7.90% | 9.19% | 67.92% | -12.70% | 36.38% | -0.78% | Upgrade
|
Capital Expenditures | -60,554 | -50,415 | -71,948 | -62,625 | -65,969 | -57,040 | Upgrade
|
Sale of Property, Plant & Equipment | - | -510 | 19,346 | 1,048 | 1,042 | -22 | Upgrade
|
Sale (Purchase) of Intangibles | -2,064 | -1,685 | 12,850 | -8,614 | -6,897 | -4,349 | Upgrade
|
Investment in Securities | -222,032 | -177,539 | 979 | -76,083 | -47,236 | -37,001 | Upgrade
|
Other Investing Activities | 2,643 | 2,784 | 1,483 | 280 | 133 | 100 | Upgrade
|
Investing Cash Flow | -282,007 | -227,365 | -37,290 | -145,994 | -118,927 | -98,312 | Upgrade
|
Issuance of Common Stock | 208 | 168 | 217 | 241 | 322 | 440 | Upgrade
|
Repurchase of Common Stock | -8 | -10 | -5 | -5 | -8 | -30 | Upgrade
|
Common Dividends Paid | -161,697 | - | - | - | - | - | Upgrade
|
Dividends Paid | -161,697 | -133,249 | -131,594 | -138,220 | -98,644 | -91,442 | Upgrade
|
Other Financing Activities | 204 | -7,915 | -7,949 | -7,657 | -9,078 | -8,465 | Upgrade
|
Financing Cash Flow | -169,512 | -141,006 | -139,331 | -145,641 | -107,408 | -99,497 | Upgrade
|
Foreign Exchange Rate Adjustments | -1,288 | 2,299 | 3,202 | 1,939 | 2,128 | 1,166 | Upgrade
|
Miscellaneous Cash Flow Adjustments | -1 | - | -1 | - | - | 1 | Upgrade
|
Net Cash Flow | -39,444 | 81,528 | 236,505 | -45,584 | 55,419 | 8,393 | Upgrade
|
Free Cash Flow | 352,810 | 397,185 | 337,977 | 181,487 | 213,657 | 147,995 | Upgrade
|
Free Cash Flow Growth | 8.24% | 17.52% | 86.23% | -15.06% | 44.37% | -3.67% | Upgrade
|
Free Cash Flow Margin | 28.87% | 33.93% | 30.41% | 14.40% | 21.37% | 18.81% | Upgrade
|
Free Cash Flow Per Share | 214.39 | 241.36 | 205.40 | 110.30 | 129.87 | 89.96 | Upgrade
|
Cash Interest Paid | 125 | 94 | 81 | 58 | 48 | 34 | Upgrade
|
Cash Income Tax Paid | 166,385 | 100,477 | 176,074 | 152,082 | 104,074 | 66,785 | Upgrade
|
Levered Free Cash Flow | 286,454 | 338,816 | 317,041 | 148,160 | 177,704 | 124,969 | Upgrade
|
Unlevered Free Cash Flow | 286,454 | 338,813 | 317,058 | 148,198 | 177,734 | 125,008 | Upgrade
|
Change in Net Working Capital | 45,114 | -20,496 | -69,932 | 145,315 | 43,954 | 32,248 | Upgrade
|
Updated Jan 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.